Thursday, March 27, 2014

Go Read Ed Silverman -- Now At WSJ! -- Vioxx® Legacy Disclosures


He's got a great new one up -- on Vioxx® legacy litigation matters.

Seriously -- just read it all. I can't do it justice. Ed's is the genuine article -- served cold, to boot.

. . . .In a little-noticed ruling, a Kentucky state judge has permitted a Brown University professor to seek disclosure of countless Vioxx documents that were marked as confidential during years of litigation over the controversial painkiller. . . .

Vioxx, you may recall, was a highly controversial and widely prescribed painkiller that Merck withdrew a decade ago over links to heart attacks and strokes. However, the documents allegedly contain fresh information about the extent to which the drug maker disclosed side effects on a timely basis and its handling of clinical trial data. . . .


The guy simply never misses a beat. And he's a trusted friend. Do trust him -- he's one savvy pharma/bioscience journo.

No comments: